Neuraxis (NRXS) Return on Sales (2022 - 2025)
Historic Return on Sales for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to 2.62%.
- Neuraxis' Return on Sales fell 500.0% to 2.62% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.09%, marking a year-over-year increase of 11600.0%. This contributed to the annual value of 2.67% for FY2024, which is 2400.0% up from last year.
- Neuraxis' Return on Sales amounted to 2.62% in Q3 2025, which was down 500.0% from 1.94% recorded in Q2 2025.
- In the past 5 years, Neuraxis' Return on Sales registered a high of 1.03% during Q2 2022, and its lowest value of 6.54% during Q3 2023.
- In the last 4 years, Neuraxis' Return on Sales had a median value of 2.34% in 2022 and averaged 2.59%.
- In the last 5 years, Neuraxis' Return on Sales crashed by -44300bps in 2023 and then soared by 39700bps in 2024.
- Over the past 4 years, Neuraxis' Return on Sales (Quarter) stood at 1.87% in 2022, then tumbled by -66bps to 3.1% in 2023, then skyrocketed by 63bps to 1.16% in 2024, then tumbled by -126bps to 2.62% in 2025.
- Its last three reported values are 2.62% in Q3 2025, 1.94% for Q2 2025, and 2.56% during Q1 2025.